I have been a long term holder and will continue to be one.
here is one reason today. Morgans rates PME as Add (1) -
Pro Medicus posted a first half profit in line with the broker, the highlight being a 30% increase in transaction volumes. The company has noted continued strength in its pipeline of new contracts, together with existing customers increasing their transaction volumes.
The broker has nonetheless trimmed its FY22 market share assumption, leading to a target cut to $32.47 from $32.79. Despite a seemingly lofty PE, the broker believes Pro Medicus can grow into its multiple over time. Add retained.
Lots of automated stop loss orders still going through on the sell side. All triggered by a few big sales.
Broker upgrades by 3% (bell potter), $30 price target Morgans, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$330.13 |
Change
5.390(1.66%) |
Mkt cap ! $34.48B | |||
| Open | High | Low | Value | Volume |
| $322.84 | $331.08 | $321.11 | $47.01M | 143.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 95 | $330.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $330.13 | 582 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| PME (ASX) Chart |